Opko Health, Inc. balance sheet
At the end of fiscal 2025, Opko Health, Inc. had total assets of $1.93bn, total liabilities of $664m and shareholders' equity of $1.27bn. It held $364m in cash against $344m of debt: net cash of $20.4m.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 43 | 18 | 72 | 27 | 186 | 97 | 194 | 169 | 91 | 96 | 85 | 72 | 135 | 153 | 96 | 427 | 364 | 301 |
| Receivables | — | 12 | 13 | 21 | 20 | 20 | 194 | 220 | 166 | 144 | 135 | 286 | 260 | 127 | 123 | 118 | 90 | 82 |
| Inventory | — | 16 | 13 | 22 | 18 | 17 | 40 | 47 | 49 | 42 | 53 | 132 | 87 | 74 | 66 | 57 | 66 | 62 |
| Total current assets | — | 57 | 100 | 79 | 243 | 143 | 454 | 484 | 349 | 318 | 324 | 523 | 823 | 395 | 309 | 662 | 582 | 500 |
| Goodwill | — | 6 | 40 | 80 | 226 | 224 | 743 | 705 | 717 | 712 | 710 | 719 | 634 | 596 | 598 | 529 | 484 | 482 |
| Total assets | — | 78 | 229 | 290 | 1,392 | 1,268 | 2,799 | 2,767 | 2,590 | 2,451 | 2,309 | 2,473 | 2,400 | 2,167 | 2,012 | 2,200 | 1,932 | 1,829 |
| Accounts payable | — | 6 | 5 | 10 | 13 | 9 | 73 | 53 | 74 | 47 | 63 | 101 | 82 | 67 | 70 | 47 | 41 | 50 |
| Deferred revenue (current) | — | — | 1 | 2 | 8 | 4 | 70 | 73 | 57 | 64 | 19 | 16 | 0 | 0 | 0 | 0 | — | — |
| Total current liabilities | — | 28 | 19 | 52 | 92 | 83 | 252 | 263 | 312 | 288 | 249 | 375 | 330 | 213 | 200 | 193 | 147 | 149 |
| Short-term debt | — | 15 | 9 | 18 | 13 | 13 | 11 | 12 | 12 | 6 | 0 | — | — | 2 | 2 | 437 | 2 | 1 |
| Long-term debt | — | — | — | 5 | 3 | 2 | 3 | 1 | 2 | 5 | 4 | 4 | 205 | 9 | 8 | 3 | 2 | 2 |
| Total debt | 0 | 29 | 18 | 38 | 224 | 145 | 84 | 56 | 128 | 143 | 280 | 276 | 220 | 290 | 216 | 611 | 344 | 349 |
| Total liabilities | — | 29 | 44 | 87 | 519 | 432 | 819 | 675 | 746 | 660 | 695 | 802 | 715 | 606 | 622 | 835 | 664 | 645 |
| Shareholders' equity | 32 | 23 | 161 | 179 | 876 | 842 | 2,000 | 2,046 | 1,844 | 1,791 | 1,615 | 1,672 | 1,685 | 1,562 | 1,389 | 1,365 | 1,268 | 1,184 |
| Non-controlling interests and other (assets − liabilities − equity) | — | 26 | 24 | 24 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net debt (negative = net cash) | −43 | 11 | −54 | 11 | 39 | 48 | −110 | −113 | 37 | 46 | 194 | 204 | 85 | 137 | 120 | 184 | −20 | 48 |
| Shares outstanding | — | 255m | 298m | 298m | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 107 | 118 | 96 | 99 | 95 | 90 | 80 | 82 |
| Inventory | 59 | 57 | 64 | 66 | 65 | 66 | 64 | 62 |
| Total current assets | 630 | 662 | 738 | 583 | 627 | 582 | 535 | 500 |
| Goodwill | 536 | 529 | 477 | 484 | 484 | 484 | 482 | 482 |
| Total assets | 2,256 | 2,200 | 2,128 | 1,973 | 1,996 | 1,932 | 1,857 | 1,829 |
| Accounts payable | 63 | 47 | 59 | 57 | 51 | 41 | 44 | 50 |
| Deferred revenue (current) | — | 0 | — | — | — | — | — | — |
| Total current liabilities | 212 | 193 | 296 | 171 | 169 | 147 | 148 | 149 |
| Short-term debt | 2 | 437 | 1 | 2 | 1 | 2 | 2 | 1 |
| Long-term debt | 4 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
| Total debt | 5 | 440 | 4 | 4 | 4 | 4 | 4 | 3 |
| Total liabilities | 853 | 835 | 817 | 676 | 690 | 664 | 652 | 645 |
| Shareholders' equity | 1,403 | 1,365 | 1,312 | 1,297 | 1,305 | 1,268 | 1,205 | 1,184 |
Compare with peers
- Alvotech balance sheet
- Emergent Biosolutions Inc. balance sheet
- Travere Therapeutics, Inc. balance sheet
- Amphastar Pharmaceuticals, Inc. balance sheet
- Pacira Biosciences, Inc. balance sheet
Head to head: ALVO vs OPKEBS vs OPKOPK vs TVTX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies